Skip to main content
SpringerLink
Log in

Neuroleptic malignant syndrome (NMS) is associated with antipsychotic use in patients with bipolar disorder

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Chen Y, Guo JJ, Patel NC, Steinbuch M, Lin XD, Buncher C.Risk of neuroleptic malignant syndrome associated with antipsychotics use in patients with bipolar disorder: a retrospective population-based case-control study. Value in Health 11: A114 abstr. PHM18, No. 3, May-Jun 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuroleptic malignant syndrome (NMS) is associated with antipsychotic use in patients with bipolar disorder. React. Wkly. 1208, 4 (2008). https://doi.org/10.2165/00128415-200812080-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812080-00011

Keywords

Search

Navigation